Effect of Neurodynamic Mobilization in Patients With Lumbar Disc Herniation
Neurodynamic Mobilization for the Management of Patients With Lumbar Disc Herniation: A Randomized Controlled Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of this randomized controlled trial was to investigate the effects of neurodynamic mobilization on pain intensity, normal joint motion, neurodynamics, functional level, and disability in patients with lumbar disc herniation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2019
CompletedFirst Submitted
Initial submission to the registry
September 17, 2025
CompletedFirst Posted
Study publicly available on registry
October 2, 2025
CompletedOctober 2, 2025
September 1, 2025
11 months
September 17, 2025
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity
Patients' rest and activity pain levels was assessed via a visual analog scale (VAS). Participants were asked to mark the intensity of pain they felt on a 10-centimeter (cm) horizontal line (0 indicates no pain, 10 indicates intolerable pain). The point marked on the line was measured with a ruler and the VAS value was recorded in cm
Pain was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment)
Secondary Outcomes (3)
ROM
Rom was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).
Neurodynamic Mobility - Slump Test
These were assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).
Neurodynamic Mobility - Sit and Reach Test
Baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment)
Study Arms (2)
Neurodynamic Mobilization + Conventional Therapy (Experimental Group)
EXPERIMENTALParticipants received the conventional physiotherapy program plus neurodynamic mobilization administered by a physical therapist. Treatment was given 5 days a week for 4 weeks, for a total of 20 sessions.
Conventional Therapy (Control Group)
ACTIVE COMPARATORIndividuals in control group received hot therapy (Hotpack, 20 minutes), Conventional Tens (60 Hz, 60 msec, 20 minutes) and Therapeutic Ultrasound (1.5 w/cm2, 10 minutes). Patients were given an exercise program to do at home and the treatment was given 5 days a week for 4 weeks, for a total of 20 sessions, to all patients in the study.
Interventions
In the experimental group, neurodynamic mobilization was applied in addition to the conventional physiotherapy program. For the neurodynamic mobilization tibial nerve neural mobilization was performed. For neural mobilization of the tibial nerve, the patient was placed in the side-lying position with the hip in 90° flexion, knee flexion and ankle dorsi flexion. In this position, the ankle and hip positions were maintained, and knee extension was performed. When the symptoms were at a level that would not disturb the patient, it was held for 5 seconds, and knee flexion was performed by plantar flexion of the ankle. This practice was performed twice a week with 10 repetitions by a physiotherapist. The same neurodynamic mobilization exercise was recommended to the patients in the neuromobilization group as a home program with 10 repetitions twice a day.
All participants received hot pack therapy (20 minutes), conventional TENS (60 Hz, 60 msec, 20 minutes), therapeutic ultrasound (1.5 W/cm², 10 minutes), and a prescribed home exercise program, delivered 5 days per week for 4 weeks (20 sessions in total).
Eligibility Criteria
You may qualify if:
- Age between 20 and 60 years
- Diagnosed with lumbar disc herniation at one or more of the L3-L4, L4-L5
- L5-S1 levels with prolapsed, protruding, or extruding disc confirmed by MRI
- Presence of low back pain for at least 6 weeks.
You may not qualify if:
- Spinal stenosis
- Previous lumbar surgery or medical treatment for disc herniation
- Pregnancy
- Severe osteoporosis
- Diabetes mellitus
- Severe neurological deficit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gazi University Department of Physical Therapy and Rehabilitation
Ankara, Çankaya, 06690, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gurkan Gunaydin
Aydin Adnan Menderes University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 17, 2025
First Posted
October 2, 2025
Study Start
June 4, 2018
Primary Completion
May 10, 2019
Study Completion
May 10, 2019
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share